SCNX
Scienture Holdings, Inc.NASDAQHEALTHCAREPHARMACEUTICAL RETAILERS
Key Statistics
Market Cap
$14.22M
P/E Ratio
—
EPS
$-2.70
Beta
—
52W High
$2.60
52W Low
$0.24
50-Day MA
$0.42
200-Day MA
$0.86
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
21.83
PEG Ratio
—
About Scienture Holdings, Inc.
Scienture Holdings, Inc. (SCNX) is an innovative biotechnology company focused on developing cutting-edge therapeutic solutions for neurological disorders. With a robust drug development pipeline supported by advanced technology and a highly skilled research team, Scienture is committed to meeting unmet medical needs and improving patient outcomes. The company's strategic emphasis on scientific excellence, regulatory compliance, and collaborative partnerships positions it well for growth within the burgeoning healthcare sector, highlighting its potential to make significant contributions to global health advancements.
Fundamentals
| Revenue (TTM) | 431,610 |
| Gross Profit (TTM) | 331,480 |
| EBITDA | $-15.79M |
| Operating Margin | 1870.00% |
| Return on Equity | -55.60% |
| Return on Assets | -10.70% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $1.73 |
| Price-to-Book | 0.18 |
| Price-to-Sales (TTM) | 32.95 |
| EV/Revenue | 13.45 |
| EV/EBITDA | -1.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 810.00% |
| Shares Outstanding | $40.63M |
| Float | $32.79M |
| % Insiders | 21.88% |
| % Institutions | 3.72% |
Data last updated: 4/9/2026